(1 - 16 from 23
)
OncoBone Ventures Receives HMRC Adcance Assurance for SEIS ...www.technologynetworks.com › Product News
www.technologynetworks.com
Jul 20, · Dr. Jussi Halleen, CEO of OncoBone Ventures commented: “Securing successful and speedy Advance Assurance from HMRC, on the back of clear and ...
PHARMATEST JOINS BIOCOM AND SCIENCE EXCHANGE IN ...mail.pharmatestservices.fi › index.php › news › pharmatest-joins-biocom-a...
mail.pharmatestservices.fi
Jussi Halleen, CEO of Pharmatest comments: “Our increased investments in US marketing in recent years have shown their value, as we have increased our US ...
Pharmatest credits Bruker for SkyScan in vivo micro-CT ...pharmatestservices.pharmatest.com › index.php › news › pharmatest-credit...
pharmatestservices.pharmatest.com
Jussi Halleen, CEO of Pharmatest says: “We are very impressed about the excellent performance of the SkyScan in vivo micro-CT equipment, ...
ValiRx PLC | Collaboration Agreement | InvestEgate
www.investegate.co.uk
Jussi Halleen, CEO of Pharmatest commented: "I wish to thank ValiRx for their trust in Pharmatest in this very important project, and we are also ...
sorted by relevance / date